Interference of the influenza A virus non-structural protein NS1 with type I interferon (IFN) signalling has been characterized extensively in vitro. To assess the contribution of NS1 to the virulence of a specific strain, we generated recombinant USSR/90/77 viruses bearing the NS1 proteins of the attenuated strain PR/8/34 or the highly pathogenic strain 1918 'Spanish flu', all belonging to the H1N1 subtype. In vitro, the extent of interference with type I IFN production exerted by the different NS1 proteins correlated with the reported virulence of the respective strain. Infection of ferrets with the recombinant viruses revealed that the presence of the 1918 NS1 resulted in a slightly more severe disease with generally higher clinical scores and increased lung pathology. Analysis of mRNA from nasal wash cells revealed that viruses carrying the 1918 and, to a lesser extent, USSR/90/77 NS1 proteins caused a delay in upregulation of type I IFNs compared with the NS1 PR/8/34-expressing virus, demonstrating the importance of NS1 for early host-response control and virulence.
INTRODUCTION
In healthy, immunocompetent individuals, most influenza viruses cause an infection of the upper respiratory tract lasting 6-10 days (Eccles, 2005) . Due to the acute nature of the infection, elements of the innate immune response, especially type I interferons (IFNs), play an important role in its control (McGill et al., 2009) . Type I IFNs are produced by most cell types in response to virus infection, resulting in the induction of an antiviral state in the infected, as well as neighbouring, cells (Haller et al., 2006) . To circumvent this response, influenza viruses have developed multiple mechanisms, including more rapid replication, interference with innate immune activation, and IFN resistance . Whilst specific mutations in the viral replication complex proteins are associated with higher replication efficiency, the nonstructural NS1 protein has been identified as the main viral immune antagonist (Krug et al., 2003; Pappas et al., 2008) and may also contribute to IFN resistance (Billharz et al., 2009; Kochs et al., 2007) . A virus lacking NS1 was a strong type I IFN and tumour necrosis factor alpha (TNF-a) inducer, and replicated efficiently only in type I IFNdeficient cells or animals (García-Sastre et al., 1998b) .
In the infected cell, NS1 interferes with the initial activation of the IFN-b signalling cascade, most probably by preventing recognition of the viral ssRNA by retinoic acid-inducible gene I (RIG-I) (Gack et al., 2009; Guo et al., 2007; Mibayashi et al., 2007; Pichlmair et al., 2006) . In addition, many NS1 proteins interfere with the nuclear export of cellular mRNAs by inhibiting their 39-end processing (Chen et al., 1999; Nemeroff et al., 1998) and subsequent complex formation with the nuclear-export machinery (Satterly et al., 2007) . By blocking the activity of several antiviral proteins, NS1 further inhibits the production of type I IFNs and pro-inflammatory cytokines, thereby suppressing the induction of an antiviral state (Min & Krug, 2006; Min et al., 2007) . Recent studies demonstrate that NS1 also prevents the maturation of infected dendritic cells, which are essential for an efficient adaptive immune response, suggesting that its immune interference activity extends beyond the innate immune system (Fernandez-Sesma et al., 2006; Haye et al., 2009) .
The contribution of NS1 to pathogenesis has been examined in different virus backbones and animal models with variable results: replacement of the NS segment of the mouse-adapted WSN strain with that of the 1918 pandemic virus resulted in attenuation in mice, even though the recombinant virus was more efficient at blocking the induction of IFN-regulated genes in a human cell line (Basler et al., 2001) . In contrast, A/ Puerto Rico/8/34 (PR/8) viruses carrying the NS gene of H5N1/97 strains, which are unable to block CPSF30 signalling , retained the mortality of the parental virus in mice, whilst the CPSF30-blocking NS gene of the H5N1/01 lineage resulted in attenuation (Lipatov et al., 2005) . The former virus also displayed an increased virulence in pigs compared with the parental PR/8 strain, which is usually non-pathogenic in this model (Seo et al., 2002) . Moreover, replacement of the NS segment of the highly virulent H5N1 strain Vietnam/1203/04 by that of a non-lethal avian H5N1 virus partially attenuated the virus in IP: 54.70.40.11
On: Fri, 02 Aug 2019 00:07:45 ferrets (Salomon et al., 2006) , suggesting that NS1 activity is highly species-and strain-specific.
Even though NS1 proteins from highly virulent strains are generally more efficient at inhibiting type I IFN signalling in vitro, infection of primates, ferrets and mice with these viruses is characterized by a strong induction of pro-inflammatory cytokines and severe inflammation in the lungs Kobasa et al., 2007; Perrone et al., 2008; Uyeki, 2009) . To characterize the contribution of NS1 to type I IFNmediated immune-response control and virulence in a host that is naturally susceptible to human viruses, we introduced the NS1 or the entire NS of the attenuated H1N1 PR/8 or the highly virulent H1N1 A/Brevig Mission/1918 Mission/ (1918 strains into the human seasonal H1N1 strain USSR/90/77 (USSR). The replication efficacy and inhibition of type I IFN production of the resulting viruses were first determined in vitro, followed by pathogenesis assessment in ferrets. Finally, mRNA-expression profiles of pro-inflammatory cytokines, type I IFN, and type I IFN-stimulated genes with known antiviral activity were generated from nasal wash cells.
RESULTS

NS1 proteins from virulent strains interfere more efficiently with cellular signalling
In vitro, NS1 proteins originating from virulent strains are more efficient at inhibiting type I IFN responses and deletion of NS1 leads to attenuation in vivo (García-Sastre et al., 1998b) , but the contribution of NS1 to the virulence of a specific strain in a naturally susceptible host remains to be elucidated. To reduce the risk of incompatibility between NS1 and the genetic backbone, H1N1 viruses of the same lineage were chosen for this study (Nelson et al., 2008) : the mouse-adapted strain PR/8, which is attenuated in ferrets; A/USSR/90/77 USSR, a seasonal strain with moderate virulence (Svitek et al., 2008) ; and 1918, which is highly virulent (Tumpey et al., 2005) .
The three NS1 proteins shared an overall amino acid identity of 93-95 %, with the PR/8 and 1918 NS1 being most closely related. None of the diverging residues in the amino-terminal region, which contains an RNA-binding domain (Chien et al., 2004) , have been associated with a specific function (Fig. 1a) . The PR/8 NS1 protein carries in its effector domain the mutations F103S and M106I, which partially abrogate binding to CPSF30, thereby impairing its capacity to inhibit host mRNA expression (Das et al., 2008; Kochs et al., 2007) . As part of a putative PDZ domain ligand, the lysine at position 227 in the 1918 NS1 was associated with higher pathogenicity and more widespread dissemination (Jackson et al., 2008) . Finally, the USSR NS1 protein contains a 7 aa extension at its very carboxy terminus, which creates a second nuclear-localization and a nucleolar-localization signal (Melén et al., 2007) .
To compare the capacity of the different NS1 proteins to inhibit IFN signalling, HeLa cells were transfected with the respective plasmids and firefly luciferase under control of IFN-stimulated response element (ISRE) or Mx1 promoters, and stimulated with universal IFN-a for 16 h. Whilst the PR/ 8 NS1 protein was unable to inhibit type I IFN transcription, and even had an enhancing effect, USSR and 1918 NS1 expression resulted in almost 80 % reduction in ISREmediated luciferase activity, and similar results were obtained for the IFN-stimulated gene Mx1 (Fig. 1b, c) . The PR/8 NS1 was also unable to interfere with nuclear factor kappa B (NFkB) signalling upon TNF-a stimulation, whilst expression of the USSR NS1 protein resulted in 70 % inhibition and the 1918 NS1 was slightly more efficient, reaching 80 % inhibition (Fig. 1d) . Analysis of NS1 protein levels in the transfected cells revealed that the lack of inhibition observed for the PR/8 NS1 was not due to reduced protein expression (Fig. 1e) , indicating that the NS1 proteins of more virulent strains possess an inherently higher inhibitory activity.
Recombinant viruses with the NS1 protein from virulent strains are better inhibitors of type I IFN production in vitro
To gain insight into the contribution of NS1 to virulence, the different NS1 genes were introduced into the USSR background, yielding rUSSR-NS1 PR/8, rUSSR and rUSSR-NS1 1918. A USSR 7 : 1 reassortant carrying the PR/8 NS segment, rUSSR-NS PR/8, was also generated. At 12 h post-infection, the recombinant viruses with PR/8 NS1 or NS reached 100-fold lower titres than the parental virus and the virus carrying the 1918 NS1 protein (P,0.001 and P,0.05, respectively) (Fig. 2a) . However, whilst the titres of rUSSR-NS PR/8 reached levels similar to those of rUSSR and rUSSR-NS1 1918 at 24 h post-infection and thereafter, the replication of rUSSR-NS1 PR/8 remained impaired. Based on these results, rUSSR-NS PR/8 was used for all further experiments.
We next assessed the amount of type I IFN induced by each of the recombinant viruses in Madin-Darby canine kidney (MDCK) cells, using a vesicular stomatitis virus (VSV) biological assay. A 10-fold inhibition of VSV replication was observed for the supernatant of rUSSR-NS PR/8 at all time points, indicating a rapid onset of type I IFN production (Fig. 2b ). rUSSR and rUSSR-NS1 1918 inhibited type I IFN production, as demonstrated by near-wild-type VSV titres at 8 and 16 h post-infection. As the infection progressed, the inhibitory effect began to decline, but the presence of the USSR or 1918 NS1 protein still resulted in a fivefold inhibitory effect at 24 h. Analysis of NS1 protein levels in the infected cells revealed that the PR/8 NS1 was expressed at levels comparable or superior to those for rUSSR and rUSSR-NS1 1918, indicating that the weaker inhibitory effect is not caused by lower protein expression levels.
NS1 slightly increases USSR virulence
To evaluate the contribution of NS1 to virulence in a naturally susceptible host, eight ferrets were infected intranasally with 10 5 TCID 50 of the respective virus. All animals experienced an increase in body temperature 1-2 days after infection, with the rUSSR-NS1 1918-infected group developing the highest peak temperature and longest duration (Fig. 3a) . Infection with rUSSR-NS1 1918 resulted in moderate to severe clinical signs indicative of upper and lower respiratory tract involvement, including large amounts of serous or seromucous nasal exudate, moderate congestion, frequent sneezing and increased respiratory rates. The animals were moderately depressed and unwilling to exercise for 3 days after infection, and recovered slowly over the following 3-5 days (Fig. 3b) . Both rUSSR and rUSSR-NS PR/8 resulted in an intermediate disease that was characterized by serous nasal exudate, mild congestion, occasional sneezing and transient reduction in activity and endurance (Fig. 3b) . Peak nasal wash titres were detected 1 day after infection, and generally declined thereafter until the virus was cleared at day 6, even though animals infected with rUSSR secreted 10-fold more virus between days 1 and 3 (Fig. 3c ).
NS1 influences spread to and replication efficiency in the lower respiratory tract
To evaluate virus replication in the upper and lower respiratory tract, two animals of each group were sacrificed 2 and 4 days after infection, and nasal turbinates and lungs were harvested. All viruses were able to infect the upper respiratory tract efficiently, reaching similar titres at 2 days post-infection (Fig. 4a) . However, whilst one of the rUSSR-NS PR/8-infected animals had already cleared the virus on "1 for the assessment of ISRE and Mx1 activation, or 10 ng TNF-a ml "1 for NF-kB activation; firefly luciferase activity was measured 16 h later and normalized to Renilla luciferase levels. The inhibition associated with the respective NS1 protein is expressed as percentage activity compared with empty-vector control. The mean of three independent experiments performed in triplicates is shown; error bars illustrate SD. (e) Western blot analysis of NS1 protein expression. HeLa cells were transfected with 2 mg of the different plasmids and harvested 36 h later. NS1 was detected by using a rabbit anti-peptide hyperimmune serum specific to a conserved peptide in NS1.
day 4 post-infection, rUSSR and rUSSR-NS1 1918 continued to replicate (Fig. 4b) . In contrast to rUSSR and rUSSR-NS1 1918, which were detectable at day 2 postinfection and persisted at least to day 4, rUSSR-NS PR/8 was not found in the lungs.
Histopathological analysis of haematoxylin and eosin (H&E)-stained lung sections from animals sacrificed 2 days after infection revealed only discrete changes, characterized by localized loss of the epithelial layer in bronchi and minimal congestion (Fig. 5, left panel) in the case of rUSSR-NS PR/8, which resolved completely by day 4 (data not shown). In contrast, rUSSR and rUSSR-NS1 1918 caused more severe pathology, with widespread loss of the bronchial epithelial layer, congestion and occasional oedema detectable on day 2 (Fig. 5 , middle and right panels) that persisted until day 4 (data not shown).
Extent of NS1 interference with IFN signalling correlates with virulence
As the USSR and 1918 NS1 proteins were more efficient than the PR/8 NS1 at blocking IFN signalling in vitro, an mRNA profile of cytokines involved in innate immune activation was generated from nasal wash cells isolated at days 1 and 3 post-infection. Comparison of the proinflammatory cytokines IP-10 and TNF-a revealed that rUSSR-NS PR/8 induced the strongest and the most rapid response, with 10-fold higher mRNA expression than , and the mean and SD, based on two independent experiments performed in duplicate, are shown. (b) Comparison of type I IFN production following infection. MDCK cells were infected as described above and supernatants were harvested at the indicated time points. UV-inactivated supernatants were tested for inhibition of VSV replication. Statistical significance: *P,0.05; **P,0.01; ***P,0.001.
rUSSR-NS1 1918 and USSR (Fig. 6a, b) . Consistent with the weak inhibition of type I IFN production by the PR/8 NS1 observed in vitro, the virus carrying the PR/8 NS segment induced significantly more IFN-b at day 1 than rUSSR and rUSSR-NS1 1918 (P,0.05), and at 3 days postinfection than rUSSR-NS1 1918 (P,0.05) (Fig. 6c) . Moreover, the presence of the PR/8 NS1 was associated with 100-fold higher IFN-a induction at day 1 postinfection compared with ferrets infected with rUSSR-NS1 1918, whilst rUSSR caused the highest IFN-a levels on day 3 (Fig. 6d) . The presence of the USSR or 1918 NS1 proteins was also associated with lower Mx1 induction (Fig. 6e) .
DISCUSSION
By limiting virus replication and spread through induction of an antiviral state in infected and surrounding noninfected cells, type I IFNs are among the first line of defence against virus infections (Haller et al., 2006) . Consequently, viruses have evolved strategies to counteract these responses. In the case of influenza A viruses, the NS1 protein contributes importantly to interference with innate immune activation, and viruses lacking NS1 were found to be attenuated in immunocompetent animals (García-Sastre et al., 1998b; Kochs et al., 2007) . However, studies investigating the contribution of NS1 to virulence and host-response control in vivo have yielded contradictory results, which may be due to genetic incompatibility of NS1 and the respective virus backbone, or the susceptibility of the animal model. Here we evaluated the pathogenesis of recombinant H1N1 USSR/77 viruses carrying either their own NS1 protein or those of the genetically similar H1N1 strains PR/8 or 1918 in ferrets, which closely reproduce the clinical signs and disease severity seen in humans. 
USSR and 1918 NS1 proteins display similar levels of type I IFN inhibition in vitro
NS1 is a multifunctional protein that interferes with innate immune activation at pre-and post-transcriptional levels (Kuo et al., 2010; Nemeroff et al., 1998) . NS1 proteins from certain strains, including PR/8 and the pandemic H1N1 2009 viruses, are no longer able to block the posttranscriptional processing of host mRNAs due to mutations in the NS1 effector domain that prevent CPSF30 binding, which reduces their capacity to interfere with type I IFN and TNF-a signalling (Hale et al., 2010; Hayman et al., 2007; Kochs et al., 2007) . However, these NS1 proteins retain their ability to bind dsRNA efficiently and to block the activity of RIG-I and IPS (IFN promoter stimulator), thereby inhibiting IFN-b induction at the pre-transcriptional level (Hale et al., 2010; Kochs et al., 2007; Mibayashi et al., 2007; Pichlmair et al., 2006) . Consistent with these reports, we observed that the PR/8 NS1 protein is unable to interfere with type I IFN signalling, but remains capable of inhibiting its production at least to a certain extent, as seen in the VSV bioassay, whilst the USSR and 1918 NS1 proteins are similarly efficient at interfering with IFN signalling and production in vitro. Thus, whilst well-suited to identification and characterization of functionally defective NS1 proteins, these in vitro assays may be limited in their ability to detect subtle differences in immune activation.
Insertion of the PR/8 NS segment results in attenuation while maintaining replication efficiency in vivo PR/8 was one of the first mouse-adapted influenza virus strains and causes severe disease and death in mice (Blazejewska et al., 2011; Grimm et al., 2007) , whilst the disease in ferrets is mild and short-lived (Svitek et al., 2008) . Here we found that introduction of the PR/8 NS1 into the USSR background resulted in a 100-fold reduction in replication efficiency, which is similar to the reduction reported for NS1-deleted viruses (García-Sastre et al., 1998b) . In contrast, a 7 : 1 reassortant carrying the entire PR/8 NS segment displayed slightly delayed replication kinetics, but yielded maximum titres similar to those for the parental USSR. This observation suggests that the PR/8 nuclear export protein (NEP) has evolved to compensate for the reduced innate immune interference capacity of PR/8 NS1, possibly by increasing viral replication efficiency (Akarsu et al., 2011; Robb et al., 2009) . In vivo, the 7 : 1 reassortant replicated as efficiently as the parental USSR virus and resulted in similar clinical scores, but was restricted to the upper respiratory tract, most probably due to the rapid and vigorous local type I IFN response. Similar effects were observed in mice for viruses carrying NS1 deletions (Ferko et al., 2004) , indicating that introduction of the PR/8 NS segment may be a simple and efficient approach to attenuation of newly emerging influenza viruses. 
How does NS1 contribute to virulence?
Whilst the mechanisms of NS1 interference with IFN signalling and activation of the antiviral state have been characterized extensively in vitro (Hayman et al., 2007; Kochs et al., 2007; Talon et al., 2000; Wang et al., 2000) , there is limited information on host-response differences in animal models. Infection of STAT12/2 and IFNaR2/2 mice with the mouse-adapted WSN strain resulted in systemic infection, demonstrating the pivotal role of type I IFNs in controlling replication and limiting spread (García-Sastre et al., 1998a) . Moreover, introduction of the 1918 NS into the seasonal H1N1 strain K173 led to dissemination to the lower respiratory tract of ferrets, in contrast to the parental virus, which replicated only in the upper respiratory tract (Watanabe et al., 2009) . Infection of ferrets with rUSSR-NS PR/8 resulted in a rapid local immune response, including high levels of type I IFNs and interferon gamma-induced protein (IP)-10, which translated into higher induction levels of Mx and probably other IFN-stimulated genes (ISGs), leading to rapid control of replication and spread. Conversely, the early inhibition of type I IFN induction mediated by the USSR and 1918 NS1 proteins was associated with a sustained replication and spread to the lungs. The sustained lack of type I IFN activation seen in the presence of the 1918 NS1 may explain the more severe lung pathology seen in these animals than in the USSR NS1 group, which experienced a peak in IFN-a transcription on day 3. Even though other NS1 functions certainly also contribute to the observed differences, our study establishes a correlation between the extent of NS1-mediated inhibition of innate immune activation at early infection stages and virulence.
METHODS
Cells and viruses. MDCK cells (ATCC CCL-34), 293 cells (ATCC CRL-1573) and HeLa cells (ATCC CCL-2) were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 5 % FBS (Invitrogen). All influenza viruses were propagated in MDCK cells cultivated in DMEM with 2 mg TPCKtrypsin ml 21 (Sigma). VSV strain Indiana was kindly provided by Dr Alain Lamarre, INRS-Institut Armand-Frappier. Influenza virus titres were determined by limiting dilution and expressed as TCID 50 ml 21 , whilst VSV titres were quantified by plaque assay and expressed as p.f.u. ml 21 .
Cloning of USSR/90/77 and NS1 genes. A bidirectional expression plasmid was generated by integrating the human RNA polymerase I promoter and terminator sequences separated by two BsmBI sites into pcDNA3.1Zeo(2), yielding pcDNApol. To clone the individual segments of USSR (Svitek & von Messling, 2007) , RNA was isolated from infected MDCK cells (RNeasy; Qiagen) and transcribed into cDNA (SuperScript III; Invitrogen) following the manufacturers' instructions. The segments were amplified by using universal influenza primers (Hoffmann et al., 2001 ) and cloned directly into pcDNApol. At least four clones of each segment were sequenced to establish the consensus sequence. The PR/8 NS segment was generated as described above, using RNA isolated from PR/8-infected MDCK cells. The PR/8 and 1918 NS1 genes were generated by introducing the respective amino acid-relevant changes into the USSR NS plasmid by using site-directed mutagenesis based on the GenBank sequences EF467817 and AF333238.1, respectively. This mutagenesis did not result in changes of the NS2 amino acid sequence. For the luciferase assays, the NS1 genes were cloned into pcDNA3.1Zeo(2) by using gene-specific primers.
Recovery of recombinant viruses. Recombinant viruses were recovered as described by Hoffmann et al. (2000) . Briefly, semiconfluent 293 cells in a six-well plate were transfected with 0.5 mg of each plasmid by using Lipofectamine 2000 (Invitrogen). Two days after transfection, cells were trypsinized and transferred onto MDCK cells seeded in a six-well plate. Co-cultures were maintained in DMEM in the presence of 2 mg TPCK-trypsin ml 21 until cytopathic effect was observed. Cells and supernatant were harvested and transferred onto fresh MDCK cells in a 75 cm 2 flask for the production of virus stocks. For growth kinetics, 90 % confluent MDCK cells were seeded in a 12-well plate. The cells were washed twice with PBS (Invitrogen) prior to infection to remove the FBScontaining medium. MDCK cells were infected at an m.o.i. of 0.001, medium was aspirated after 30 min to remove unbound virus, and cells were then cultivated in DMEM with 2 mg TPCK-trypsin ml
21
. Cells and supernatant were harvested every 12 h for 2 days and virus titres were determined by limiting dilution.
Luciferase reporter-gene assays. Triplicate wells of HeLa cells seeded in 24-well plates were transfected with 450 ng of the respective NS1 expression plasmids or empty-vector control, and 100 ng phRG-TK (Promega) as internal control for transfection efficiency, in combination with 450 ng of pISRE-luc (Stratagene) for assessment of type I IFN-mediated activation, of pMx1-luc (Schumacher et al., 1994) for natural ISG activation, or of NF-kB-luc (Stratagene). At 24 h post-transfection, cells were stimulated with 1000 U universal type I IFN-a ml 21 (PBL Interferon Source) or 10 ng TNF-a ml
(R&D Systems). After 16 h, cells were scraped, centrifuged at 330 g and transferred to a black 96-well plate (BrandTek; Tekniscience), where they were lysed in Dual-Glo luciferase assay lysis buffer (Promega) and luciferase activity was measured by using a TriLux luminometer (Perkin-Elmer). Values of firefly luciferase activity were normalized to Renilla luciferase activity, and results are expressed as a percentage of the empty-vector control-stimulated value.
Western blot. Cells were washed in cold PBS and lysed on ice in 200 ml RIPA buffer [50 mM Tris (pH 7.5), 1 % Triton X-100, 0.5 % deoxycholate, 0.1 % SDS and 500 mM NaCl] containing protease inhibitor cocktail (Complete; Roche Diagnostics). The lysate was centrifuged at 17 000 g for 30 min at 4 uC and stored at 280 uC. Protein lysates were mixed with SDS/gel loading buffer containing 20 % b-mercaptoethanol (Sigma), separated by SDS-PAGE (12 % gel), transferred to Immobilon-P PVDF membranes (Millipore Corporation) and blocked overnight in blocking buffer (Roche Diagnostics).
NS1 was detected by using a rabbit anti-peptide hyperimmune serum raised against the keyhole limpet haemocyanin-coupled peptide DRLRRDQKSLRGRSC (Sheldon Biotechnology Centre, McGill University, Montreal, QC), which is conserved in NS1 proteins from different subtypes. After incubation with a horseradish peroxidaseconjugated secondary antibody (Sigma), NS1 was visualized using the ECL Plus Western blotting detection system (GE Healthcare) and exposed on a Kodak Image Station 2000.
VSV biological assay. MDCK cells were infected at an m.o.i. of 0.001 and supernatant was harvested at 8, 16 and 24 h post-infection. IFN activity of UV-inactivated samples (Arnheiter & Staeheli, 1983) ) and infected intranasally with 10 5 TCID 50 of the respective virus. Body temperature was recorded every 30 min using intraperitoneal implants (DSI), starting 1 day before infection. Clinical signs and treadmill endurance were monitored daily for the first 4 days and every second day thereafter. The clinical score was established following a 0-1-2-3 scale, with 0 always representing the physiological range. Clinical signs were scored as follows. Quantity of nasal exudate: 1, little (wet nose); 2, larger amounts (runny nose); 3, copious amount. Quality of nasal exudate: 1, serous; 2, seromucous; 3, mucopurulent. Sneezing: 1, rarely (once during observation period); 2, occasionally (between two and five times during observation period); 3, frequently (more than five times). Congestion: 1, mild (breathing sounds congested); 2, intermediate (occasional mouth breathing); 3, severe (mouth breathing). Coughing: 1, rarely (once during observation period); 2, occasionally (between two and five times during observation period); 3, frequently (more than five times). Respiratory rate min 21 : 1, 30-35; 2, 35-40; 3, .40. Dyspnoea: 1, occasional wheezing; 2, continuous wheezing; 3, laboured breathing. Activity: 1, calm; 2, depressed; 3, inactive. Treadmill endurance: 1, 2-4 min; 2, ,2 min; 3, 0 min. Nasal washes were collected daily for the first 4 days and on day 6. Towards this, 500 ml PBS was instilled in one nostril and the expectorate was collected in a 50 ml centrifuge tube. The procedure was repeated until a minimal volume of 400 ml was recovered. The virus was titrated by limiting dilution and expressed as TCID 50 ml 21 . At days 2 and 4 post-infection, two animals were sacrificed and the nasal turbinates and the lower right lung lobe were collected for virus titration and histopathological analysis.
Tissue titration and histopathological analysis. Formalin-fixed tissues were paraffin-embedded, cut into 5 mm sections and stained with H&E. For quantification of viral load, tissues were weighed and homogenized in DMEM with 5 % FBS on a bead mill homogenizer (Tissue Lyser; Qiagen). Cell debris was pelleted by centrifugation at 16 000 g for 30 s and the supernatant was titrated by limiting dilution. The titre is expressed as TCID 50 (g tissue) 21 .
Cytokine mRNA quantification by quantitative real-time PCR.
Immediately after collection, 140 ml nasal wash fluid was mixed with 560 ml AVL buffer (QIAamp Viral RNA Mini kit; Qiagen) and stored at 280 uC. The RNA was extracted following the manufacturer's instructions. The genes encoding ferret IFN-a, IFN-b, TNF-a, Mx1 (GenBank accession no. JF906988) and IP-10 were cloned into the pCR2.1-TOPO vector (Invitrogen) based on previously published sequences Svitek & von Messling, 2007; Svitek et al., 2008) . RNA standards for each gene were produced by in vitro transcription from the respective plasmid using T7 RNA polymerase (New England Biolabs). Serial dilutions of the RNA standards and the sample RNA were analysed by real-time RT-PCR using a QuantiTect SYBR Green RT-PCR kit (Qiagen) as described previously (Svitek et al., 2008) . The number of RNA copies was determined according to the following formula: number of copies5amount of RNA (ng)66.022610 23 /gene length (bp)610 9 6340.
Statistical analysis. The statistical analyses were performed using GraphPad Prism 5.0a. Data were analysed by a one-way analysis of variance followed by Tukey's a posteriori test to determine significant differences.
